{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:28:25Z","timestamp":1758040105447,"version":"3.44.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ahj.2019.10.019","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T11:09:53Z","timestamp":1574852993000},"page":"148-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Validation of the all-comers design: Results of the TARGET-AC substudy"],"prefix":"10.1016","volume":"221","author":[{"given":"Gabor","family":"G Toth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Lansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Baumbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Kelb\u00e6k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"van Royen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"Holmvang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Brugaletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinand","family":"Kiemeneij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph Kurt","family":"Naber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Pucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter N\u00f8rkj\u00e6r","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Ameloot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios","family":"Milkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Sevilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Wijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2019.10.019_bb0005","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/j.1939-4640.2001.tb03433.x","article-title":"Is the randomized clinical trial the gold standard of research?","volume":"22","author":"Simon","year":"2001","journal-title":"J Androl"},{"key":"10.1016\/j.ahj.2019.10.019_bb0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/bmj.316.7126.201","article-title":"Understanding controlled trials. Why are randomised controlled trials important?","volume":"316","author":"Sibbald","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2019.10.019_bb0015","doi-asserted-by":"crossref","unstructured":"Lansky A, Wijns W, Xu B, Kelb\u00e6k H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina C, Buszman P, Thiele H, Sch\u00e4chinger V, Baumbach A; TARGET All Comers Investigators. Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial. Lancet. 2018 Sep 29;392(10153):1117\u20131126. doi: https:\/\/doi.org\/10.1016\/S0140-6736(18)31649-0.","DOI":"10.1016\/S0140-6736(18)31649-0"},{"key":"10.1016\/j.ahj.2019.10.019_bb0020","doi-asserted-by":"crossref","unstructured":"Zaman A, de Winter RJ, Kogame N, Chang CC, Modolo R, Spitzer E, Tonino P, Hofma S, Zurakowski A, Smits PC, Prokopczuk J, Moreno R, Choudhury A, Petrov I, Cequier A, Kukreja N, Hoye A, Iniguez A, Ungi I, Serra A, Gil RJ, Walsh S, Tonev G, Mathur A, Merkely B, Colombo A, Ijsselmuiden S, Soliman O, Kaul U, Onuma Y, Serruys PW; TALENT trial investigators. Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial. Lancet. 2019 Mar 9;393(10175):987\u2013997. doi: https:\/\/doi.org\/10.1016\/S0140-6736(18)32467-X.","DOI":"10.1016\/S0140-6736(18)32467-X"},{"key":"10.1016\/j.ahj.2019.10.019_bb0025","doi-asserted-by":"crossref","unstructured":"Colombo A, Chandrasekhar J, Aquino M, Ong TK, Sartori S, Baber U, Lee M, Iniguez A, Hajek P, Borisov B, Atzev B, Den Heijer P, Coufal Z, Hudec M, Mates M, Snyder C, Moalem K, Morrell D, Elmore F, Rowland S, Mehran R; MASCOT Investigators. Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry. Int J Cardiol. 2019 May 15;283:67\u201372. doi: https:\/\/doi.org\/10.1016\/j.ijcard.2019.01.053.","DOI":"10.1016\/j.ijcard.2019.01.053"},{"issue":"24","key":"10.1016\/j.ahj.2019.10.019_bb0030","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.jacc.2018.09.013","article-title":"Intravascular ultrasound versus angiography-guided drug-eluting stent implantation: The ULTIMATE trial","volume":"72","author":"Zhang","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10149","key":"10.1016\/j.ahj.2019.10.019_bb0035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(18)31715-X","article-title":"Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial","volume":"392","author":"Pilgrim","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2019.10.019_bb0040","doi-asserted-by":"crossref","unstructured":"Claudio Cavallo, Mohamed A Labib, Norissa Honea, Peter Nakaji, Letter: Enrollment-to-screening ratio: an undervalued data in randomized clinical trials, Neurosurgery, 2018;82:184\u2013185","DOI":"10.1093\/neuros\/nyy079"},{"key":"10.1016\/j.ahj.2019.10.019_bb0045","doi-asserted-by":"crossref","unstructured":"de Boer SP, Lenzen MJ, Oemrawsingh RM, Simsek C, Duckers HJ, van der Giessen WJ, Serruys PW, Boersma E. Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participants. Eur Heart J. 2011 Sep;32(17):2161\u20137. doi: https:\/\/doi.org\/10.1093\/eurheartj\/ehr126.","DOI":"10.1093\/eurheartj\/ehr126"},{"key":"10.1016\/j.ahj.2019.10.019_bb0050","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/eurheartj\/ehi731","article-title":"Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization","volume":"27","author":"Hordijk-Trion","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2019.10.019_bb0055","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1053\/euhj.1999.1690","article-title":"Comparing outcomes of percutaneous transluminal coronary angioplasty with coronary artery bypass grafting; can routine health service data complement and enhance randomized controlled trials?","volume":"20","author":"Lewsey","year":"1999","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2019.10.019_bb0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1015327801114","article-title":"Clinical trials and the real world: sampling bias and generalisability of trial results","volume":"16","author":"Sharpe","year":"2002","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319303242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319303242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:04:48Z","timestamp":1757570688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870319303242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":12,"alternative-id":["S0002870319303242"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2019.10.019","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the all-comers design: Results of the TARGET-AC substudy","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2019.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}